L’anticorps anti-CSGALNACT2 Polyclonal Lapin est utilisé pour la détection de CSGALNACT2 dans des échantillons de Humain et Souris. Il a été validé pour ELISA, IHC et IF.
CSGALNACT2
Reactivité: Humain
ELISA, WB
Hôte: Lapin
Polyclonal
FITC
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300,ELISA 1:40000,IF 1:50-200
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
CSGALNACT2, CHGN2, GALNACT2, Chondroitin sulfate N-acetylgalactosaminyltransferase 2, Chondroitin beta-1, 4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. The encoded protein is involved in elongation during chondroitin sulfate synthesis. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome X.